IDEXX Laboratories, Inc. vs Utilities Select Sector SPDR Fund — how do they compare? IDEXX Laboratories, Inc. trades at $558.29 (market cap $44.48B), while Utilities Select Sector SPDR Fund trades at $44.8. The key difference: Utilities Select Sector SPDR Fund is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | XLU | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | — |
52-Week High | $766.68 | $47.73 |
52-Week Low | $520.87 | $41.31 |
Enterprise Value | $45.38B | — |
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
XLU trades at $44.93, down 0.51% on the day, with a bearish technical signal from moving averages while oscillators remain neutral. The ETF benefits from growing AI-driven electricity demand, highlighted by recent news of utility stocks gaining traction as data center power needs strain the grid. Support sits at $44, with resistance at $46.
Outlook is cautiously optimistic due to structural power demand tailwinds from AI and clean energy transitions, though regulatory risks and execution challenges pose headwinds. The ETF offers defensive exposure with dividend income, but investors should monitor utility sector capacity investments and interest rate sensitivity.
Trailing returns across standard periods
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →